- UroToday Home
- Pelvic Health & Reconstruction
The Latest Research in Overactive Bladder
Recent Abstracts
-
The Effect of Midurethral Slings on Overactive Bladder Medication Use in Women with Mixed Urinary Incontinence.Overactive BladderAugust 9, 2026
-
Optimizing Percutaneous Tibial Nerve Stimulation Intensity for Overactive Bladder Using a Motion Capture System.Overactive BladderAugust 9, 2026
-
Role of periaqueductal gray matter in bladder overactivity induced by vesical adaptation response to diuresis in rats.Overactive BladderAugust 9, 2026
-
Urinary Peptide Signatures Distinguish Overactive Bladder and are Associated with Improvement in Incontinence Following Therapy.Overactive BladderAugust 9, 2026
-
Transcutaneous tibial neuromodulation, is the future of neuromodulation here?Overactive BladderAugust 2, 2026
-
Clinical Resource Use in Patients Undergoing Intradetrusor Abotulinum Toxin A Injections for Neurogenic Compared to Non-Neurogenic Indications-The Potential for Compensation Inequities for Urologic and Urogynecologic Practices.Overactive BladderAugust 2, 2026
-
Reduced-Dose OnabotulinumtoxinA for Urgency Incontinence in Older Women: Methods.Overactive BladderAugust 2, 2026
-
Intravaginal Delivery of Oxybutynin: An Alternative Administration Route to Improve its Pharmacokinetic and Pharmacodynamic Effects.Overactive BladderAugust 2, 2026
-
Association Between Childbirth and Overactive Bladder Symptoms: A Nationwide Internet-Based Study of 4800 Japanese Women.Overactive BladderJuly 26, 2026
-
Comparing the safety and efficacy of vibegron, mirabegron and tolterodine in patients with overactive bladder: a systematic review and network meta-analysis.Overactive BladderJuly 26, 2026
Beyond the Abstracts
-
Long-Term Safety of Overactive Bladder Medications in Men Receiving Pharmacotherapy for Benign Prostatic Enlargement: A Real-World Study Using Inverse Probability of Treatment Weighting - Beyond the AbstractOveractive BladderJuly 1, 2026
-
Overactive Bladder after Gender Affirming Vaginoplasty - Beyond the AbstractOveractive BladderMarch 31, 2026
-
Pharmacotherapy for Overactive Bladder Syndrome and the Risk of Incident Dementia - Beyond the AbstractOveractive BladderMay 29, 2025
-
Comparisons of Urinary Bladder Responses to Common Antimuscarinics Reveals Unique Effects of Darifenacin - Beyond the AbstractOveractive BladderMay 22, 2025
-
A First-In-Human Feasibility Study of a New Implantable Tibial Nerve Stimulator for Overactive Bladder Syndrome - Beyond the AbstractOveractive BladderMay 5, 2025
-
Mirabegron versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review - Beyond the AbstractOveractive BladderMarch 10, 2025
-
Antibiotic Therapy for Treating Overactive Bladder Is Not Supported by Clinical Evidence - Beyond the AbstractOveractive BladderFebruary 27, 2025
-
Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the AbstractOveractive BladderJuly 23, 2024
-
Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices - Beyond the AbstractOveractive BladderJuly 1, 2024
-
Factors Influencing Medication Selection for Management of Overactive Bladder: Trends and Insights from AUA Quality Registry - Beyond the AbstractOveractive BladderFebruary 7, 2024